By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Media HydeMedia Hyde
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Font ResizerAa
Media HydeMedia Hyde
Font ResizerAa
  • Home
  • Politics
  • Education
  • Entertainment
  • Sports
  • Blogs
  • Business & Commerce
  • Others
    • Religious
    • Metropolitan
    • Climate and Weather
Follow US
© 2026 Media Hyde Network. All Rights Reserved.
Health

Just One Week Of Reduced Social Media Use Brings Positive Mental Health Improvements

Last updated: November 30, 2025 12:20 am
Neha Ashraf
Share
SHARE

‎A study has revealed that even one week of significantly reduced social media use can improve various aspects of mental health in young people.

‎In today’s world, social media has become the center of life for many young people, providing communication with friends, news, and stress related content all on a single screen.

‎A new study has found that staying away from social media for just one week can reduce anxiety, depression, and sleep problems.

‎Researchers observed 295 young people aged 14 to 24, who reduced their daily screen time from about two hours to just 30 minutes.

‎After one week, a survey of these young people showed that their symptoms of anxiety, depression, and insomnia had significantly decreased, especially among those who had previously experienced severe depression.

‎According to the study, this step led to a 16 percent reduction in anxiety symptoms, nearly 25 percent reduction in depression, and a 14.5 percent decrease in insomnia.

‎The study also found that feelings of loneliness among the participants remained unchanged despite reduced social media use.

‎Experts say that reducing social media use is beneficial, but it should not be considered the only or primary treatment for mental health conditions.

‎The research has been published, and its co author is Dr. John Torous, an associate professor of psychiatry at Harvard Medical School.

Share This Article
Email Copy Link Print
Previous Article Son Arrested for Killing Father as Swabi Police Solve Blind Murder Case
Next Article New York Times Reports Disclosure Of Child Deaths Linked To COVID-19 Vaccine
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Sponsored Ads

Stay Connected

FacebookLike
XFollow
InstagramFollow
YoutubeSubscribe
WhatsAppFollow
ThreadsFollow
Fake Horse Passports Fueled Massive Illegal Equine Trafficking Ring
Fake Horse Passports Fueled Massive Illegal Equine Trafficking Ring
Court & Crime Headline
September 11, 2026
Sheen Claims Foreign Minister Ignored Pollution Concerns
Sheen Claims Foreign Minister Ignored Pollution Concerns
Climate and Weather Headline
September 11, 2026
Four former presidents join NYC’s solemn 25th anniversary of 9/11
Four former presidents join NYC’s solemn 25th anniversary of 9/11
Headline international
September 11, 2026
European Green Crabs Overrun Puget Sound: A Fight Against Ecological Collapse
European Green Crabs Overrun Puget Sound: A Fight Against Ecological Collapse
Climate and Weather Headline
September 11, 2026
Punjab on high alert as final monsoon spell nears
Punjab on high alert as final monsoon spell nears
Climate and Weather Headline
September 11, 2026
Rare species face extinction threat in Snowdonia National Park
Rare species face extinction threat in Snowdonia National Park
Climate and Weather Headline
September 11, 2026

You Might Also Like

WASHINGTON: UnitedHealth has warned that the Trump administration’s planned Medicare obesity-drug pilot faces “notable challenges,” casting doubt over how smoothly the program can move ahead if major insurers stay cautious. Recent market reporting said the model depends heavily on participation from Medicare drug plans that cover most Part D enrollees, which makes the stance of large insurers especially important. The concern centers on a broader CMS effort to expand access to GLP-1 weight-loss medicines for seniors. Under CMS’s published framework, the longer-term BALANCE Model would begin in Medicare Part D in January 2027, while a temporary Medicare GLP-1 Bridge is designed to start earlier and give eligible beneficiaries short-term access before that main model begins. What makes this a little more complicated is that the short-term bridge and the longer pilot are not the same thing. CMS says the Medicare GLP-1 Bridge operates outside the normal Part D coverage and payment flow, meaning Part D sponsors are not directly involved in that bridge arrangement. In other words, insurer participation is a much bigger issue for the 2027 BALANCE rollout than for the bridge itself. That distinction matters because investors and drugmakers are watching this closely. Reports said shares of obesity-drug makers fell after UnitedHealth’s comments, largely because Medicare coverage is seen as a huge growth opportunity for drugs such as Wegovy and Zepbound. If major insurers hesitate, the program could struggle to achieve the scale CMS appears to want. There is already some evidence of resistance. MarketWatch reported that CVS Health has opted out, while UnitedHealth is still evaluating the structure and discussing possible changes with Medicare officials. That does not mean the program is dead, not yet anyway, but it does suggest the administration may need to revise the design or sweeten the terms if it wants broader insurer buy-in. The bigger backdrop here is cost. Medicare has long been wary of broad obesity-drug coverage because GLP-1 therapies are expensive and potentially involve very large patient populations. Earlier policy debates around these drugs were shaped by concerns that wide coverage could drive up federal spending sharply, even as supporters argued the medicines could reduce longer-term health costs tied to obesity. So the headline problem for CMS is pretty straightforward: it has created a short-term bridge that can move without direct Part D plan involvement, but the more ambitious long-term Medicare model still appears to need insurers on board. UnitedHealth’s warning does not shut the door, but it does signal that one of the industry’s biggest players thinks the current setup may not be ready for easy launch.
HeadlineHealth

UnitedHealth raises red flags over Medicare obesity-drug pilot

By
Mabruka Khan
Health

Flu and COVID in One Jab? Novavax’s New Vaccine Passes Big Test

By
Fatima Nadeem
RDA Reaffirms Commitment to Dengue-Free Rawalpindi on World Dengue Day
Health

RDA Reaffirms Commitment to Dengue-Free Rawalpindi on World Dengue Day

By
Misbah Jogyat
Health

Key Appointments and Transfers in Lahore’s Mayo and Ganga Ram Hospitals

By
Neha Ashraf
Media Hyde Media Hyde Dark
Facebook Twitter Youtube Rss Medium

About US

Media Hyde Network: Your instant connection to breaking stories and live updates. Stay informed with our real-time coverage across politics, tech, entertainment, and more. Your reliable source for 24/7 News.

Top Categories
  • Headline
  • Politics
  • Entertainment
  • Education
  • Sports
  • Religious
  • Metropolitan
  • Climate and Weather
Usefull Links
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Cookies Policy
  • Advertising Policy
  • Terms & Conditions

© 2025 Media Hyde Network. All Rights Reserved.

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?